chrX-150776287-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_031462.4(CD99L2):āc.542T>Cā(p.Val181Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000183 in 1,204,215 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_031462.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD99L2 | NM_031462.4 | c.542T>C | p.Val181Ala | missense_variant | 9/11 | ENST00000370377.8 | NP_113650.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD99L2 | ENST00000370377.8 | c.542T>C | p.Val181Ala | missense_variant | 9/11 | 1 | NM_031462.4 | ENSP00000359403.3 |
Frequencies
GnomAD3 genomes AF: 0.000107 AC: 12AN: 112223Hom.: 0 Cov.: 23 AF XY: 0.000145 AC XY: 5AN XY: 34395
GnomAD3 exomes AF: 0.0000179 AC: 3AN: 167373Hom.: 0 AF XY: 0.0000369 AC XY: 2AN XY: 54183
GnomAD4 exome AF: 0.00000916 AC: 10AN: 1091992Hom.: 0 Cov.: 30 AF XY: 0.00000838 AC XY: 3AN XY: 357942
GnomAD4 genome AF: 0.000107 AC: 12AN: 112223Hom.: 0 Cov.: 23 AF XY: 0.000145 AC XY: 5AN XY: 34395
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2024 | The c.554T>C (p.V185A) alteration is located in exon 9 (coding exon 9) of the CD99L2 gene. This alteration results from a T to C substitution at nucleotide position 554, causing the valine (V) at amino acid position 185 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at